Teva Pharmaceutical Industries Ltd (TEVJF) Preferred Shares (2015 - 2018)
Teva Pharmaceutical Industries' (TEVJF) quarterly Preferred Shares came in at $3.8 billion in Q3 2018, up 5.66% YoY from $3.6 billion in Q3 2017, and up 1.73% on a QoQ basis from $3.8 billion in Q2 2018.
Teva Pharmaceutical Industries Ltd (TEVJF) Preferred Shares (2015 - 2018) Analysis & Trends
Teva Pharmaceutical Industries (TEVJF) has 4 years of Preferred Shares data on file, last reported at $3.8 billion in Q3 2018.
- Quarterly Preferred Shares rose 5.66% year-over-year to $3.8 billion in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $3.8 billion (up 5.66% YoY) and the FY2017 annual result came in at $3.6 billion, changed 0.3% from the prior year.
- Preferred Shares rose to $3.8 billion in Q3 2018, from $3.8 billion in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $3.8 billion in Q3 2018 to a low of $3.3 billion in Q4 2015.
- A 4-year average of $3.6 billion and a median of $3.6 billion in 2016 frame the typical range for Preferred Shares.
- Annual changes were most pronounced in 2016 — Preferred Shares advanced 10.0% — and 2017, when it changed 0.0%.
- Tracing TEVJF's Preferred Shares over 4 years: stood at $3.3 billion in 2015, then rose by 10.0% to $3.6 billion in 2016, then advanced by 0.3% to $3.6 billion in 2017, then increased by 5.34% to $3.8 billion in 2018.
- The last three Preferred Shares figures came in at $3.8 billion (Q3 2018), $3.8 billion (Q2 2018), and $3.7 billion (Q1 2018), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 3.83 Bn |
| Jun 30, 2018 | 3.76 Bn |
| Mar 31, 2018 | 3.70 Bn |
| Dec 31, 2017 | 3.63 Bn |
| Sep 30, 2017 | 3.62 Bn |
| Jun 30, 2017 | 3.62 Bn |
| Mar 31, 2017 | 3.62 Bn |
| Dec 31, 2016 | 3.62 Bn |
| Sep 30, 2016 | 3.62 Bn |
| Jun 30, 2016 | 3.62 Bn |
| Mar 31, 2016 | 3.62 Bn |
| Dec 31, 2015 | 3.29 Bn |